87 research outputs found

    Measuring the impact of ICNIRP vs. stricter-than-ICNIRP exposure limits on QoS and EMF from cellular networks

    Get PDF
    The installation of new equipment (Base Stations, BSs) during the planning phase of a cellular network (including 5G BSs) is governed by exposure limits in terms of allowable ElectroMagnetic Field (EMF) levels. The exposure limits can be either defined by (i) international bodies (e.g., ICNIRP) or (ii) national regulations imposing limits stricter than (i). In this work, we compare the impact of ICNIRP vs. stricter-than-ICNIRP exposure regulations on the Quality of Service (QoS) and EMF. To this aim, we perform a large-scale measurement campaign in one scenario in Spain subject to ICNIRP regulations and another one in Italy subject to EMF limits stricter than ICNIRP ones. Both the scenarios are characterized by similar exposure conditions, comparable user density, and common 4G performance targets by the operators. Results, obtained by measuring QoS and EMF at selected locations, reveal that the QoS in the scenario subject to strict EMF limits is heavily worsened compared to the one in which ICNIRP-based limits are enforced. Clearly, the scenario with strict EMF limits presents a lower level exposure over the territory compared to the one imposing ICNIRP limits

    Joint energy efficiency and load balancing optimization in hybrid IP/SDN networks

    Get PDF
    Software-defined networking (SDN) is a paradigm that provides flexibility and programmability to computer networks. By introducing SDN nodes in a legacy IP network topology, network operators can benefit on higher control over the infrastructure. However, this migration is not a fast or straightforward process. Furthermore, to provide an adequate quality of service in hybrid IP/SDN networks, the coordination of both IP and SDN paradigm is fundamental. In this paper, this coordination is used to solve two optimization problems that are typically solved separately: (i) traffic load balancing and (ii) power consumption minimization. Each of these problems has opposing objectives, and thus, their joint consideration implies striking a balance between them. Therefore, this paper proposes the Hybrid Spreading Load Algorithm (HSLA) heuristic that jointly faces the problems of balancing traffic by minimizing link utilization and network's power consumption in a hybrid IP/SDN network. HSLA is evaluated over differently sized topologies using different methods to select which nodes are migrated from IP to SDN. These evaluations reveal that alternative approaches that only address one of the objectives are outperformed by HSLA

    Dynamic in-network classification for service function chaining ready SDN networks

    Get PDF
    Service Function Chaining (SFC) paradigm consists in steering traffic flows through an ordered set of Service Functions (SFs) so that to realize complex end to end services. SFC architecture introduces all the logical functions that need to be developed in order to provide the required service. The SFC overlay infrastructure can be built on top of many different underlay network technologies. The high flexibility and centrally controlled feature of Software Defined Networking (SDN), make SDN networks to be a perfect underlay to build the SFC architecture. Due to Ternary Content Address Memory (TCAM) limited size, SDN switches have a limitation in the number of flow rules that can be hosted. This constraint is particularly penalizing in case of the SFC classifier function, since it requires to manage a high number of different flows. The limitation imposed by the TCAM size on the SFC classifier can be a bottleneck for the number of SFC requests that the SDN-based SFC architecture can handle. In this paper we define the Dynamic Chain Request Classification Offloading (D-CRCO) problem, as the one of maximizing the number of accepted SFC requests, having the possibility of: i) implement the SFC classifier also in a node that is internal to the SDN-based SFC domain, and ii) install classification rules in a reactive fashion. Furthermore, we propose the Dynamic Nearest Node (DNN) heuristic to solve the D-CRCO problem. Performance evaluation shows that by using DNN heuristic it is possible to triple the number of accepted requests, with respect to existing solutions

    Live Demonstration:Neuromorphic Sensory Integration for Combining Sound Source Localization and Collision Avoidance

    Get PDF
    The brain is able to solve complex tasks in real time by combining different sensory cues with previously acquired knowledge. Inspired by the brain, we designed a neuromorphic demonstrator which combines auditory and visual input to find an obstacle free direction closest to the sound source. The system consists of two event-based sensors (the eDVS for vision and the NAS for audition) mounted onto a pan-tilt unit and a spiking neural network implemented on the SpiNNaker platform. By combining the different sensory information, the demonstrator is able to point at a sound source direction while avoiding obstacles in real time

    X chromosome inactivation does not necessarily determine the severity of the phenotype in Rett syndrome patients

    Get PDF
    Rett syndrome (RTT) is a severe neurological disorder usually caused by mutations in the MECP2 gene. Since the MECP2 gene is located on the X chromosome, X chromosome inactivation (XCI) could play a role in the wide range of phenotypic variation of RTT patients; however, classical methylation-based protocols to evaluate XCI could not determine whether the preferentially inactivated X chromosome carried the mutant or the wild-type allele. Therefore, we developed an allele-specific methylation-based assay to evaluate methylation at the loci of several recurrent MECP2 mutations. We analyzed the XCI patterns in the blood of 174 RTT patients, but we did not find a clear correlation between XCI and the clinical presentation. We also compared XCI in blood and brain cortex samples of two patients and found differences between XCI patterns in these tissues. However, RTT mainly being a neurological disease complicates the establishment of a correlation between the XCI in blood and the clinical presentation of the patients. Furthermore, we analyzed MECP2 transcript levels and found differences from the expected levels according to XCI. Many factors other than XCI could affect the RTT phenotype, which in combination could influence the clinical presentation of RTT patients to a greater extent than slight variations in the XCI pattern

    Coronavirus Gene 7 Counteracts Host Defenses and Modulates Virus Virulence

    Get PDF
    Transmissible gastroenteritis virus (TGEV) genome contains three accessory genes: 3a, 3b and 7. Gene 7 is only present in members of coronavirus genus a1, and encodes a hydrophobic protein of 78 aa. To study gene 7 function, a recombinant TGEV virus lacking gene 7 was engineered (rTGEV-Δ7). Both the mutant and the parental (rTGEV-wt) viruses showed the same growth and viral RNA accumulation kinetics in tissue cultures. Nevertheless, cells infected with rTGEV-Δ7 virus showed an increased cytopathic effect caused by an enhanced apoptosis mediated by caspase activation. Macromolecular synthesis analysis showed that rTGEV-Δ7 virus infection led to host translational shut-off and increased cellular RNA degradation compared with rTGEV-wt infection. An increase of eukaryotic translation initiation factor 2 (eIF2α) phosphorylation and an enhanced nuclease, most likely RNase L, activity were observed in rTGEV-Δ7 virus infected cells. These results suggested that the removal of gene 7 promoted an intensified dsRNA-activated host antiviral response. In protein 7 a conserved sequence motif that potentially mediates binding to protein phosphatase 1 catalytic subunit (PP1c), a key regulator of the cell antiviral defenses, was identified. We postulated that TGEV protein 7 may counteract host antiviral response by its association with PP1c. In fact, pull-down assays demonstrated the interaction between TGEV protein 7, but not a protein 7 mutant lacking PP1c binding motif, with PP1. Moreover, the interaction between protein 7 and PP1 was required, during the infection, for eIF2α dephosphorylation and inhibition of cell RNA degradation. Inoculation of newborn piglets with rTGEV-Δ7 and rTGEV-wt viruses showed that rTGEV-Δ7 virus presented accelerated growth kinetics and pathology compared with the parental virus. Overall, the results indicated that gene 7 counteracted host cell defenses, and modified TGEV persistence increasing TGEV survival. Therefore, the acquisition of gene 7 by the TGEV genome most likely has provided a selective advantage to the virus

    Risk Factors Associated with Adverse Fetal Outcomes in Pregnancies Affected by Coronavirus Disease 2019 (COVID-19): A Secondary Analysis of the WAPM study on COVID-19

    Get PDF
    To evaluate the strength of association between maternal and pregnancy characteristics and the risk of adverse perinatal outcomes in pregnancies with laboratory confirmed COVID-19. Secondary analysis of a multinational, cohort study on all consecutive pregnant women with laboratory-confirmed COVID-19 from February 1, 2020 to April 30, 2020 from 73 centers from 22 different countries. A confirmed case of COVID-19 was defined as a positive result on real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay of nasal and pharyngeal swab specimens. The primary outcome was a composite adverse fetal outcome, defined as the presence of either abortion (pregnancy loss before 22 weeks of gestations), stillbirth (intrauterine fetal death after 22 weeks of gestation), neonatal death (death of a live-born infant within the first 28 days of life), and perinatal death (either stillbirth or neonatal death). Logistic regression analysis was performed to evaluate parameters independently associated with the primary outcome. Logistic regression was reported as odds ratio (OR) with 95% confidence interval (CI). Mean gestational age at diagnosis was 30.6\ub19.5 weeks, with 8.0% of women being diagnosed in the first, 22.2% in the second and 69.8% in the third trimester of pregnancy. There were six miscarriage (2.3%), six intrauterine device (IUD) (2.3) and 5 (2.0%) neonatal deaths, with an overall rate of perinatal death of 4.2% (11/265), thus resulting into 17 cases experiencing and 226 not experiencing composite adverse fetal outcome. Neither stillbirths nor neonatal deaths had congenital anomalies found at antenatal or postnatal evaluation. Furthermore, none of the cases experiencing IUD had signs of impending demise at arterial or venous Doppler. Neonatal deaths were all considered as prematurity-related adverse events. Of the 250 live-born neonates, one (0.4%) was found positive at RT-PCR pharyngeal swabs performed after delivery. The mother was tested positive during the third trimester of pregnancy. The newborn was asymptomatic and had negative RT-PCR test after 14 days of life. At logistic regression analysis, gestational age at diagnosis (OR: 0.85, 95% CI 0.8-0.9 per week increase; p<0.001), birthweight (OR: 1.17, 95% CI 1.09-1.12.7 per 100 g decrease; p=0.012) and maternal ventilatory support, including either need for oxygen or CPAP (OR: 4.12, 95% CI 2.3-7.9; p=0.001) were independently associated with composite adverse fetal outcome. Early gestational age at infection, maternal ventilatory supports and low birthweight are the main determinants of adverse perinatal outcomes in fetuses with maternal COVID-19 infection. Conversely, the risk of vertical transmission seems negligible

    Effectiveness of an mHealth intervention combining a smartphone app and smart band on body composition in an overweight and obese population: Randomized controlled trial (EVIDENT 3 study)

    Get PDF
    Background: Mobile health (mHealth) is currently among the supporting elements that may contribute to an improvement in health markers by helping people adopt healthier lifestyles. mHealth interventions have been widely reported to achieve greater weight loss than other approaches, but their effect on body composition remains unclear. Objective: This study aimed to assess the short-term (3 months) effectiveness of a mobile app and a smart band for losing weight and changing body composition in sedentary Spanish adults who are overweight or obese. Methods: A randomized controlled, multicenter clinical trial was conducted involving the participation of 440 subjects from primary care centers, with 231 subjects in the intervention group (IG; counselling with smartphone app and smart band) and 209 in the control group (CG; counselling only). Both groups were counselled about healthy diet and physical activity. For the 3-month intervention period, the IG was trained to use a smartphone app that involved self-monitoring and tailored feedback, as well as a smart band that recorded daily physical activity (Mi Band 2, Xiaomi). Body composition was measured using the InBody 230 bioimpedance device (InBody Co., Ltd), and physical activity was measured using the International Physical Activity Questionnaire. Results: The mHealth intervention produced a greater loss of body weight (–1.97 kg, 95% CI –2.39 to –1.54) relative to standard counselling at 3 months (–1.13 kg, 95% CI –1.56 to –0.69). Comparing groups, the IG achieved a weight loss of 0.84 kg more than the CG at 3 months. The IG showed a decrease in body fat mass (BFM; –1.84 kg, 95% CI –2.48 to –1.20), percentage of body fat (PBF; –1.22%, 95% CI –1.82% to 0.62%), and BMI (–0.77 kg/m2, 95% CI –0.96 to 0.57). No significant changes were observed in any of these parameters in men; among women, there was a significant decrease in BMI in the IG compared with the CG. When subjects were grouped according to baseline BMI, the overweight group experienced a change in BFM of –1.18 kg (95% CI –2.30 to –0.06) and BMI of –0.47 kg/m2 (95% CI –0.80 to –0.13), whereas the obese group only experienced a change in BMI of –0.53 kg/m2 (95% CI –0.86 to –0.19). When the data were analyzed according to physical activity, the moderate-vigorous physical activity group showed significant changes in BFM of –1.03 kg (95% CI –1.74 to –0.33), PBF of –0.76% (95% CI –1.32% to –0.20%), and BMI of –0.5 kg/m2 (95% CI –0.83 to –0.19). Conclusions: The results from this multicenter, randomized controlled clinical trial study show that compared with standard counselling alone, adding a self-reported app and a smart band obtained beneficial results in terms of weight loss and a reduction in BFM and PBF in female subjects with a BMI less than 30 kg/m2 and a moderate-vigorous physical activity level. Nevertheless, further studies are needed to ensure that this profile benefits more than others from this intervention and to investigate modifications of this intervention to achieve a global effect

    Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

    Get PDF
    Aims: This study aimed to assess age- and sex-related differences in management and 1-year risk for all-cause mortality and hospitalization in chronic heart failure (HF) patients. Methods and results: Of 16 354 patients included in the European Society of Cardiology Heart Failure Long-Term Registry, 9428 chronic HF patients were analysed [median age: 66 years; 28.5% women; mean left ventricular ejection fraction (LVEF) 37%]. Rates of use of guideline-directed medical therapy (GDMT) were high (angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers and mineralocorticoid receptor antagonists: 85.7%, 88.7% and 58.8%, respectively). Crude GDMT utilization rates were lower in women than in men (all differences: P\ua0 64 0.001), and GDMT use became lower with ageing in both sexes, at baseline and at 1-year follow-up. Sex was not an independent predictor of GDMT prescription; however, age >75 years was a significant predictor of GDMT underutilization. Rates of all-cause mortality were lower in women than in men (7.1% vs. 8.7%; P\ua0=\ua00.015), as were rates of all-cause hospitalization (21.9% vs. 27.3%; P\ua075 years. Conclusions: There was a decline in GDMT use with advanced age in both sexes. Sex was not an independent predictor of GDMT or adverse outcomes. However, age >75 years independently predicted lower GDMT use and higher all-cause mortality in patients with LVEF 6445%
    • 

    corecore